≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Oral lichen ruber planus

Endpoint Browser PheWeb

K11_ORAL_LICHEN_PLANUS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K13.74
  • Cause of death: ICD-10 — K13.74

2 out of 7 registries used, show all original rules.

820

4. Check minimum number of events

None

820

5. Include endpoints

None

820

6. Filter based on genotype QC (FinnGen only)

820

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF6

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3550 2602 940
Only index persons 3534 2596 938
Unadjusted period prevalence (%)
Whole population 0.06 0.07 0.03
Only index persons 0.08 0.10 0.04
Median age at first event (years)
Whole population 63.69 64.61 61.30
Only index persons 63.76 64.64 61.30

-FinnGen-

Key figures

All Female Male
Number of individuals 820 636 184
Unadjusted period prevalence (%) 0.19 0.22 0.08
Median age at first event (years) 64.96 64.84 65.35

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
718
Matched controls
7179
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
+∞
323.0
718
34
EKA10
NOMESCO Finland
Biopsy of cheek
77.1
274.2
305
68
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
37.1
197.6
257
106
L43.8
ICD-10 Finland
Other lichen planus
46.7
169.8
208
62
SBA00
NOMESCO Finland
Microbiological examinations
37.0
165.9
215
82
SAA03
NOMESCO Finland
Extended examination of mouth
9.2
153.7
559
1984
L43.9
ICD-10 Finland
Lichen planus, unspecified
37.3
149.5
193
70
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
25.3
104.8
150
74
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.1
91.0
440
1691
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
25.9
89.7
127
59
D07AC01
ATC
betamethasone; topical
5.0
87.2
439
1731
WZB00
NOMESCO Finland
Telephone receipt or other advice
5.0
85.4
391
1386
ECA20
NOMESCO Finland
Biopsy of gingiva
46.7
82.8
101
25
D07AD01
ATC
clobetasol; topical
5.8
81.9
283
723
K13.78
ICD-10 Finland
Other change in the oral mucosa
21.2
76.3
115
64
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
11.4
71.8
142
152
A07AA02
ATC
nystatin; oral
8.6
68.1
160
232
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
10.7
64.8
132
148
K13.29
ICD-10 Finland
Indefinite leukoplakia
33.8
58.2
76
25
L43
ICD-10 Finland
Lichen planus
28.1
56.9
78
31
L43.0
ICD-10 Finland
Hypertrophic lichen planus
72.5
53.1
60
9
SAA04
NOMESCO Finland
Special inverstigation of mouth
6.8
38.8
103
172
SAA01
NOMESCO Finland
Simple examination of mouth
3.2
37.4
584
4139
L43.3
ICD-10 Finland
Subacute (active) lichen planus
43.6
36.7
45
11
B37.08
ICD-10 Finland
Other candidal stomatitis
26.2
35.4
49
20
SAA02
NOMESCO Finland
Basic examination of mouth
2.9
34.9
537
3660
SXA10
NOMESCO Finland
Epithel biopsy of mouth
20.7
34.9
52
27
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
2.7
34.3
361
1959
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
5.5
31.7
99
202
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
55.6
31.6
37
7
TEA00
NOMESCO Finland
Biopsy of lip
22.8
28.6
41
19
D20
ICPC
Mouth/tongue/lip symptom/complaint
6.0
27.3
79
146
XQ802
NOMESCO Finland
Epicutan test
5.7
27.3
82
159
WX110
NOMESCO Finland
Local anesthesy
2.6
26.9
552
4057
SBB10
NOMESCO Finland
Teeth copy
5.2
26.6
86
182
R01AD11
ATC
triamcinolone; nasal
3.7
26.5
126
388
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
7.6
25.1
60
85
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
2.5
23.1
231
1150
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
37.7
23.1
29
8
J02AC01
ATC
fluconazole; systemic
2.2
22.5
382
2451
K13.20
ICD-10 Finland
Idiopathic leukoplakia
28.4
22.4
30
11
A01AC01
ATC
triamcinolone; local oral
7.9
22.0
51
69
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
30.1
22.0
29
10
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
21.9
254
1360
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
20.9
345
2158
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.0
20.0
84
230
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
6.1
19.1
53
93
K12.10
ICD-10 Finland
Stomatitis NOS
35.4
19.0
24
7
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
18.5
420
2942
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
33.9
18.1
23
7
E0000UV
ATC
NA
2.0
18.0
325
2071
D05BB02
ATC
acitretin; oral
8.2
18.0
40
51
A01AB09
ATC
miconazole; local oral
3.0
17.5
107
391
K12.18
ICD-10 Finland
Other forms of stomatitis
15.3
17.3
28
19
K05.30
ICD-10 Finland
Periodontitis complex
2.7
16.6
129
547
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
5.3
16.4
51
103
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
16.4
437
3187
K02.1
ICD-10 Finland
Caries of dentine
1.9
16.2
426
3085
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
15.8
256
1539
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.8
15.5
107
422
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.7
15.4
111
450
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
9.5
15.3
31
34
SDA02
NOMESCO Finland
Parodonthologic therapy
2.0
15.3
274
1710
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.9
15.2
50
108
A01AB04
ATC
amphotericin B; local oral
3.9
15.2
63
171
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
20.6
15.2
22
11
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.3
15.0
158
786
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.1
14.8
198
1097
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
81.8
14.6
16
*
SXC03
NOMESCO Finland
Other oral or dental procedure
11.7
14.4
26
23
SXC05
NOMESCO Finland
Other oral or dental procedure
3.5
14.2
67
203
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
43.4
14.2
17
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
14.1
94
363
Z01.2
ICD-10 Finland
Dental examination
1.9
13.7
323
2198
L28.0
ICD-10 Finland
Lichen simplex chronicus
8.6
13.6
29
35
EDB00
NOMESCO Finland
Partial excision of mandible
76.6
13.6
15
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.8
13.6
427
3198
ULA02
NOMESCO Finland
Kolposcopy
2.7
13.5
99
402
EHA10
NOMESCO Finland
Biopsy of palate
18.7
13.4
20
11
N77.8*L43.9
ICD-10 Finland
Vulvovaginal ulceration and inflammation caused by lichen ruber planus
26.3
13.4
18
7
EJ2S1
NOMESCO Finland
Photography of oral mucosa
26.3
13.4
18
7
D07AC13
ATC
mometasone; topical
1.9
13.4
233
1423
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.8
13.4
92
361
L43.1
ICD-10 Finland
Bullous lichen planus
40.9
13.2
16
*
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.8
13.0
86
328
H02AB06
ATC
prednisolone; systemic
1.8
12.8
358
2558
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.9
12.2
209
1258
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.9
12.2
206
1236
D82
ICPC
Teeth/gum disease
1.8
12.1
261
1704
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.4
11.6
105
479
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
8.3
11.6
25
31
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
15.3
11.3
18
12
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.6
11.0
37
83
R13
ICD-10 Finland
Dysphagia
3.0
10.9
62
216
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
3.0
10.8
63
224
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
10.4
343
2520
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.1
10.4
59
204
L44.3
ICD-10 Finland
Lichen ruber moniliformis
+∞
10.4
10
*
EJ2S1
SPAT
NA
+∞
10.4
10
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
10.3
167
980
SBA10
NOMESCO Finland
Measurement of excretion of saliva
7.6
10.2
23
31
SXA20
NOMESCO Finland
Local application of medicine to mouth
3.1
10.2
57
195
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
10.1
355
2647
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.7
10.1
333
2439
R01AD09
ATC
mometasone; nasal
1.7
10.1
341
2514
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
26.4
9.8
13
5
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
20.4
9.8
14
7
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.8
9.8
194
1215
LEB00
NOMESCO Finland
Biopsy of vagina
4.7
9.7
32
71
TLE00
NOMESCO Finland
Dilatation of vagina
55.7
9.7
11
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
10.2
9.6
18
18
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
9.5
103
513
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
9.4
332
2462
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
9.3
90
422
A02BC05
ATC
esomeprazole; systemic
1.6
9.3
323
2384
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.5
9.2
75
326
K03.66
ICD-10 Finland
Tooth plaque
2.8
9.2
58
218
EBB10
NOMESCO Finland
Insertion of dental implant
6.4
9.1
23
37
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
9.1
199
1280
R06AX27
ATC
desloratadine; oral
1.7
9.1
206
1342
EBA00
NOMESCO Finland
Extraction of tooth
1.7
9.1
237
1611
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
6.6
9.0
22
34
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
9.0
257
1793
N89.5
ICD-10 Finland
Stricture and atresia of vagina
18.9
9.0
13
7
K13.03
ICD-10 Finland
Keilit UNS
24.3
8.9
12
5
E000001
ATC
NA
1.9
8.9
158
948
K11.70
ICD-10 Finland
Hypoptyalism
12.7
8.9
15
12
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.0
8.8
112
596
EKB00
NOMESCO Finland
Excision of lesion of cheek
14.2
8.7
14
10
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
50.6
8.7
10
*
WZA90
NOMESCO Finland
Other doctors statement
1.8
8.6
174
1094
EMAK
NOMESCO Finland
NA
3.7
8.5
36
102
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
+∞
8.3
8
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
8.2
55
214
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
4.0
8.1
31
80
H03AA01
ATC
levothyroxine sodium; systemic
1.7
8.1
197
1304
SPA02
NOMESCO Finland
Preparation for dental prosthetics
4.2
8.1
29
71
M01AH05
ATC
etoricoxib; oral
1.6
8.0
434
3533
J01DB01
ATC
cefalexin; oral
1.7
8.0
571
4995
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.9
310
2329
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
6.2
7.9
20
33
P01BA02
ATC
hydroxychloroquine; oral
2.2
7.9
83
407
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
15.2
7.7
12
8
K03.64
ICD-10 Finland
Dental calculus supragingival
1.7
7.7
199
1337
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.6
7.6
299
2240
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.5
7.6
58
241
R01AD12
ATC
fluticasone furoate; nasal
1.6
7.6
218
1507
EJB40
NOMESCO Finland
Hemiglossectomy
25.3
7.6
10
*
D83
ICPC
Mouth/tongue/lip disease
9.0
7.6
15
17
A07EA02
ATC
hydrocortisone; rectal
4.7
7.6
24
52
SFA00
NOMESCO Finland
Small filling
2.0
7.5
101
548
ECA30
NOMESCO Finland
Excision of lesion of gingiva
6.1
7.4
19
32
N03AX09
ATC
lamotrigine; oral
3.1
7.4
39
132
ZYC01
NOMESCO Finland
Remote contact by phone
3.2
7.3
37
121
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.1
7.3
83
422
D06BX01
ATC
metronidazole; topical
2.1
7.2
87
452
XQ800
NOMESCO Finland
Prick test
2.3
7.2
64
288
WX105
SPAT
NA
30.3
7.2
9
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
30.3
7.2
9
*
Z70.8
ICD-10 Finland
Other sex counselling
30.3
7.2
9
*
K14.9
ICD-10 Finland
Disease of tongue, unspecified
20.2
7.1
10
5
R06AE07
ATC
cetirizine; oral
1.5
7.1
321
2474
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
7.1
307
2345
D07XC01
ATC
betamethasone, combinations; topical
2.0
7.1
88
465
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
6.9
77
389
-1
NOMESCO Finland
NA
1.6
6.9
223
1582
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
13.9
6.9
11
8
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
6.9
87
463
K14.61
ICD-10 Finland
Glossodynia
6.8
6.8
16
24
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
6.8
181
1219
LFA00
NOMESCO Finland
Incision of vulva or perineum
16.9
6.8
10
6
A07EA06
ATC
budesonide; oral, local oral
3.2
6.7
33
106
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
6.6
178
1204
D19
ICPC
Teeth/gum symptom/complaint
1.6
6.6
190
1305
UJF32
NOMESCO Finland
Coloscopy
1.6
6.6
199
1386
E000006
ATC
NA
2.2
6.6
63
298
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
6.5
106
616
R05
ICD-10 Finland
Cough
1.7
6.5
148
954
EAA10
NOMESCO Finland
Excision of lesion of lip
5.4
6.5
18
34
L01
ICPC
Neck symptom/complaint
1.8
6.5
107
625
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
6.4
83
442
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
6.4
81
427
N06AA09
ATC
amitriptyline; systemic
1.9
6.3
88
483
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
2.6
6.3
44
176
SPA51
NOMESCO Finland
Determination of bite and dental arch location, demanding
7.1
6.2
14
20
M79.1
ICD-10 Finland
Myalgia
1.9
6.2
95
542
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.5
6.2
409
3385
G01AA10
ATC
clindamycin; vaginal
1.7
6.2
132
836
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.1
252
1888
WX290
NOMESCO Finland
Other blockade of nerve
1.5
6.1
287
2209
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
8.7
6.1
12
14
KMAK
NOMESCO Finland
NA
1.5
6.1
350
2815
GBB00
NOMESCO Finland
Tracheostomy
6.8
6.1
14
21
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.9
6.0
93
531
R52.9
ICD-10 Finland
Pain, unspecified
2.1
6.0
66
332

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
195
88
28.76
274.67
2.2
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
285
895
4.35
81.85
2.2
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
542
3044
3.30
57.79
2.9
2.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
48
48
10.56
42.83
1.7
1.4
u/ml
17.7
22.0
—
13
7
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
45
44
10.76
40.76
1.5
1.3
titre
31.7
62.0
—
6
5
(40768443) Skin Pathology biopsy report
103
321
3.53
27.74
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
196
1009
2.24
19.66
1.5
1.3
titre
777.9
569.0
0.55
47
226
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
428
2968
1.92
18.56
2.2
2.0
pmol/l
101.2
96.9
0.90
192
1457
(3021960) Folate [Moles/volume] in Serum or Plasma
274
1666
1.97
17.32
1.6
1.5
nmol/l
21.8
21.7
0.03
237
1400
(3006315) Basophils [#/volume] in Blood
489
3596
1.89
17.17
7.2
5.7
e9/l
0.0
0.0
0.07
429
3099
(3007164) IgA [Mass/volume] in Serum or Plasma
236
1370
2.01
16.98
1.5
1.5
g/l
2.4
2.4
0.01
151
805
(3013115) Eosinophils [#/volume] in Blood
499
3714
1.88
16.64
7.4
6.0
e9/l
0.2
0.2
0.23
441
3254
(3019198) Lymphocytes [#/volume] in Blood
493
3656
1.87
16.63
7.3
5.7
e9/l
1.8
1.9
1.38
441
3210
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
262
1592
1.95
16.44
1.4
1.2
u/ml
1.5
1.6
0.12
66
409
(3001604) Monocytes [#/volume] in Blood
484
3583
1.86
16.26
7.2
5.7
e9/l
0.5
0.6
1.89
428
3081
(42870588) Differential panel, method unspecified - Blood
354
2429
1.80
14.80
7.2
5.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
431
3142
1.78
14.60
5.1
4.5
g/l
36.1
35.7
0.82
407
2928
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
678
5704
2.09
14.33
8.6
7.5
u/l
76.7
78.2
0.33
643
5349
(36660697) Celiac disease serology panel - Serum
118
570
2.25
13.47
1.2
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
456
3434
1.74
13.31
7.8
6.0
%
28.8
28.3
0.48
428
3189
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
264
1707
1.81
13.11
2.5
2.1
mg/l
3.0
3.1
0.20
230
1451
(3015377) Calcium [Moles/volume] in Serum or Plasma
364
2583
1.74
13.08
3.1
3.4
mmol/l
2.4
2.4
0.44
318
2242
(3018010) Neutrophils/100 leukocytes in Blood
451
3396
1.73
13.07
7.4
5.8
%
56.0
56.9
0.92
425
3167
(3019069) Monocytes/100 leukocytes in Blood
446
3365
1.71
12.68
8.0
6.2
%
8.8
8.5
1.27
424
3136
(3022096) Basophils/100 leukocytes in Blood
435
3261
1.71
12.66
7.6
5.9
%
0.7
0.7
0.46
410
3025
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
675
5752
1.98
12.55
5.3
4.2
pmol/l
14.9
14.8
0.57
621
5213
(3006504) Eosinophils/100 leukocytes in Blood
444
3353
1.71
12.52
7.5
5.9
%
3.0
2.9
0.40
418
3108
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
424
3172
1.70
12.30
2.6
2.3
nmol/l
79.2
78.6
0.14
390
2821
(3013650) Neutrophils [#/volume] in Blood by Automated count
529
4228
1.71
11.74
10.2
9.2
e9/l
3.6
4.0
4.86
477
3709
(3013707) Erythrocyte sedimentation rate by Westergren method
641
5426
1.83
11.42
5.3
4.3
mm/h
13.2
12.6
0.41
595
4998
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
50
172
3.03
11.38
1.3
1.2
u/ml
65.4
43.8
—
8
19
(3013826) Glucose [Moles/volume] in Serum or Plasma
518
4141
1.68
11.24
5.2
4.6
mmol/l
6.6
6.7
0.40
495
3894
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
750
6722
2.36
11.05
6.5
5.1
mu/l
1.9
2.1
0.73
690
6128
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
50
178
2.93
10.72
1.3
1.2
u/ml
1.1
6.5
—
6
14
(3007853) Bacteria identified in Skin by Aerobe culture
140
784
1.95
10.69
1.7
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
57
219
2.72
10.62
1.4
1.2
u/ml
8.3
2.8
—
8
25
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
57
224
2.66
10.17
1.4
1.2
u/ml
2.6
5.9
0.81
11
39
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
28
6.18
9.95
4.7
2.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
775
7100
2.67
9.94
16.4
13.9
mg/l
19.7
22.2
1.41
627
5527
(40768797) Stomach Pathology biopsy report
178
1100
1.79
9.92
1.5
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
483
3861
1.61
9.87
6.1
6.2
umol/l
10.5
10.8
0.32
463
3669
(3001122) Ferritin [Mass/volume] in Serum or Plasma
388
2974
1.58
9.25
3.2
2.7
ug/l
102.4
115.8
0.99
363
2726
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
203
1327
1.70
9.22
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
320
2351
1.59
9.12
3.6
3.2
u/l
29.5
30.5
0.46
305
2246
(3048689) Calprotectin [Mass/mass] in Stool
143
849
1.83
9.04
2.6
2.1
ug/g
177.5
125.1
0.45
108
674
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
313
2301
1.58
8.82
3.2
2.4
u/l
56.8
56.8
0.00
287
2113
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
457
3670
1.55
8.65
7.1
6.6
mmol/l
1.2
1.2
0.21
391
3106
(3032080) INR in Blood by Coagulation assay
367
2817
1.55
8.45
5.9
8.6
inr
1.2
1.2
0.74
128
806
(3011397) Hemoglobin [Presence] in Urine by Test strip
240
1675
1.61
8.33
4.2
3.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
100
545
1.95
8.20
3.1
2.9
g/l
10.5
10.4
0.13
95
498
(3025130) Human papilloma virus identified in Specimen
27
78
3.55
8.15
1.9
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
263
1895
1.57
7.90
6.6
6.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
575
4913
1.57
7.85
5.0
4.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
15
28
5.44
7.75
2.5
1.2
ug/l
8.2
9.0
0.37
15
28
(3019550) Sodium [Moles/volume] in Serum or Plasma
793
7450
2.96
7.75
18.3
15.9
mmol/l
139.5
139.8
1.99
780
7256
(3019309) Folate [Moles/volume] in Red Blood Cells
195
1317
1.63
7.65
1.8
1.7
nmol/l
1240.5
1229.9
0.06
153
978
(3023103) Potassium [Moles/volume] in Serum or Plasma
793
7470
2.87
7.32
18.4
16.0
mmol/l
4.0
4.0
0.05
778
7265
(4062490)
22
60
3.74
7.22
1.9
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
813
7859
5.04
7.21
26.0
20.9
e12/l
4.4
4.4
0.12
801
7637
(3035941) MCH [Entitic mass]
813
7858
5.05
7.21
25.9
20.8
pg
30.3
30.3
0.42
806
7742
(3024731) MCV [Entitic volume]
813
7857
5.07
7.20
25.9
20.9
fl
91.3
91.2
0.24
806
7741
(3007461) Platelets [#/volume] in Blood
813
7856
5.09
7.19
26.0
20.9
e9/l
251.5
255.4
1.03
804
7657
(3000963) Hemoglobin [Mass/volume] in Blood
813
7862
4.99
7.05
26.1
21.0
g/l
134.0
134.0
0.02
806
7745
(3010813) Leukocytes [#/volume] in Blood
813
7860
5.02
7.03
26.0
21.0
e9/l
6.3
6.6
3.36
801
7636
(3033658) Prothrombin time (PT) actual/Normal
245
1778
1.54
6.99
3.9
3.7
%
94.0
93.1
0.24
239
1732
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
543
4635
1.51
6.97
3.5
3.1
u/l
45.6
46.6
0.09
498
4299
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
64
316
2.11
6.89
2.3
2.3
u/l
43.5
40.4
0.59
56
278
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
218
1547
1.56
6.86
1.8
1.7
pmol/l
264481334.6
25876234.0
1.46
183
1256
(3031040) Bacteria [#/volume] in Urine by Automated count
550
4719
1.50
6.79
5.0
4.6
—
2547.8
—
0
70
(3009261) Glucose [Presence] in Urine by Test strip
435
3565
1.47
6.76
4.0
3.8
estimate
0.0
0.0
0.80
71
630
(3022948) Iron [Moles/volume] in Serum or Plasma
161
1070
1.63
6.66
2.1
2.3
umol/l
13.3
13.2
0.09
151
987
(3035350) Ketones [Presence] in Urine by Test strip
427
3495
1.46
6.63
3.9
3.8
estimate
0.0
0.0
0.00
74
655
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
413
3363
1.46
6.56
6.2
5.8
mmol/l
1.2
1.2
0.04
374
3027
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
801
7622
3.20
6.52
13.6
10.8
u/l
25.7
25.1
0.51
772
7348
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
735
6770
1.83
6.51
6.4
5.9
mmol/mol
39.5
39.9
0.67
683
6255
(3021601) Nitrite [Presence] in Urine by Test strip
429
3535
1.45
6.31
5.3
5.2
estimate
0.0
0.0
0.50
74
649
(3024980) IgG subclass 4 [Mass/volume] in Serum
28
98
2.92
6.26
1.8
1.8
g/l
0.6
0.9
0.91
21
79
(3017143) Hepatitis C virus Ab [Presence] in Serum
108
656
1.74
6.25
1.4
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
42
183
2.36
6.11
1.2
1.1
titre
156.0
77.1
—
5
14
(3012095) Magnesium [Moles/volume] in Serum or Plasma
169
1159
1.58
6.10
3.3
3.2
mmol/l
0.8
0.8
0.19
160
1081
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
186
1308
1.55
6.01
1.4
1.3
u/ml
19.4
11.3
0.42
51
487
(3004789) Transferrin [Mass/volume] in Serum or Plasma
148
987
1.61
6.01
2.1
2.3
g/l
2.4
2.4
0.80
138
917
(3022145) Colonoscopy Study observation
131
849
1.65
5.96
1.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
53
258
2.13
5.94
1.5
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
96
2.87
5.88
1.5
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
740
6872
1.79
5.79
15.3
13.0
ml/min/173m2
79.8
79.3
0.29
627
5648
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
189
1344
1.53
5.78
1.4
1.3
iu/ml
30.2
32.5
0.09
62
445
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
38
163
2.40
5.74
1.4
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
285
2206
1.45
5.70
2.2
2.1
u/l
153.3
181.8
0.80
264
2082
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
55
277
2.06
5.65
1.5
1.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
19
58
3.33
5.33
2.6
3.5
mg/l
13.4
16.0
0.17
12
41
(3005322) IgE [Units/volume] in Serum or Plasma
80
468
1.79
5.27
1.4
1.2
u/ml
109.5
158.5
1.02
74
427
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
91
2.80
5.24
1.8
1.6
%
51.3
62.6
0.59
14
61
(3023520) Reticulocytes [#/volume] in Blood
93
571
1.71
5.18
3.2
2.8
e9/l
70.4
75.0
0.55
76
431
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
81
483
1.75
5.01
1.8
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
95
2.68
4.86
1.5
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
146
1018
1.53
4.84
1.8
2.0
—
—
—
0
0
(4035726)
107
696
1.62
4.78
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
96
2.65
4.76
1.5
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
115
764
1.59
4.71
4.9
4.6
u/l
226.4
254.1
1.42
108
727
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
398
3347
1.37
4.65
4.2
4.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
134
928
1.53
4.57
2.1
2.3
%
22.3
22.7
0.10
111
787
(3019150) Specific gravity of Urine by Refractometry
201
1516
1.43
4.47
4.4
4.2
kg/l
1.0
1.0
0.57
28
213
(40760892) CBC W Ordered Manual Differential panel - Blood
206
1562
1.43
4.44
5.6
4.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
60
3.04
4.42
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
60
3.04
4.42
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
60
3.04
4.42
1.4
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
132
918
1.52
4.41
6.8
6.6
—
—
—
0
0
(3044889) 12 lead EKG panel
579
5191
1.39
4.41
4.3
3.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
473
4109
1.36
4.38
2.7
2.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
754
7128
1.72
4.34
5.3
4.7
mmol/l
5.9
5.9
0.01
684
6473
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
264
2099
1.38
4.30
2.5
2.9
ng/l
702.9
1012.0
1.47
220
1770
(3036481) Cortisol [Moles/volume] in Serum or Plasma
103
685
1.58
4.20
2.7
2.1
nmol/l
387.3
367.3
0.42
97
626
(3003458) Phosphate [Moles/volume] in Serum or Plasma
130
911
1.51
4.19
5.5
4.9
mmol/l
1.0
1.0
0.31
122
835
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
221
1712
1.40
4.19
2.5
2.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
62
2.95
4.19
1.2
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
112
762
1.54
4.14
2.7
2.8
%
1.8
1.9
0.63
100
683
(4010399)
86
554
1.62
4.01
1.5
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
51
284
1.85
3.99
1.4
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
278
2251
1.36
3.98
2.5
2.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
59
2.92
3.92
1.5
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
59
2.92
3.92
1.5
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
59
2.92
3.92
1.5
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
95
2.46
3.83
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
23
95
2.46
3.83
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
131
937
1.47
3.82
1.4
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
42
223
1.93
3.80
1.4
1.5
ug/g
277.8
296.8
0.25
24
134
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
96
2.44
3.75
1.5
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
75
476
1.63
3.72
3.4
3.1
e9/l
4.4
4.0
0.49
53
359
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
25
4.04
3.70
1.4
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
207
1617
1.37
3.68
1.6
1.7
mg/l
0.9
1.2
1.41
162
1233
(3019225) pH of Specimen
109
757
1.51
3.67
4.7
4.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
90
600
1.56
3.65
3.2
3.0
g/l
68.0
67.1
0.75
83
549
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
117
826
1.49
3.64
2.6
2.7
umol/l
6.2
7.8
0.81
99
726
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
40
3.29
3.63
1.8
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
773
7403
1.77
3.62
16.0
13.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
121
863
1.47
3.58
1.5
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
52
302
1.77
3.57
1.2
1.6
—
9.6
—
0
8
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
181
1397
1.38
3.45
2.6
2.9
mmol/l
2.4
2.5
0.72
160
1230
(3011412) CD3 cells [#/volume] in Blood
16
58
2.79
3.43
2.6
1.8
e9/l
1.0
1.2
—
10
33
(40761535) Cells panel - Urine sediment
86
577
1.55
3.40
3.3
3.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
13
42
3.13
3.38
1.6
1.8
%
14.1
13.6
—
7
21
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
57
346
1.70
3.37
1.1
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
62
389
1.64
3.24
2.1
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
144
1082
1.40
3.21
1.5
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
145
1094
1.40
3.16
1.7
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
78
525
1.54
3.06
2.7
2.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
268
2234
1.30
2.98
4.2
3.9
ph
7.4
7.4
0.14
52
410
(3004616) Nuclear Ab [Presence] in Serum
22
101
2.21
2.95
1.6
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
33
177
1.90
2.95
1.4
1.7
e6/l
14523.4
16788.4
0.10
24
136
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
79
543
1.50
2.82
1.9
3.2
ng/l
106.3
184.2
1.18
71
493
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
17
71
2.42
2.81
1.4
1.1
u/ml
93.2
70.5
—
5
6
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
171
1349
1.34
2.81
3.6
3.9
ng/l
153.7
370.2
1.44
123
1039
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
318
2727
1.27
2.79
3.6
3.5
ng/l
28.0
45.4
0.50
205
1920
(3018095) Leukocytes [#/volume] in Urine
294
2499
1.28
2.77
3.8
3.6
e6/l
78.3
94.1
0.15
196
1760
(3029937) Albumin [Presence] in Urine by Test strip
229
1887
1.30
2.75
4.6
4.1
estimate
0.0
0.0
0.88
72
641
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
105
768
1.42
2.73
1.4
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
248
2075
1.28
2.63
1.7
1.7
mmol/l
1.3
1.4
0.83
211
1730
(3003327) Ova and parasites identified in Stool by Light microscopy
38
222
1.75
2.62
1.7
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
7
7.18
2.55
1.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
11
5.49
2.54
1.0
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
275
2340
1.26
2.52
2.9
3.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
219
1821
1.28
2.42
4.2
4.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
51
331
1.58
2.38
1.7
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
74
522
1.46
2.36
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
98
2.07
2.33
2.0
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
761
7349
1.49
2.32
5.7
5.2
mmol/l
2.8
2.8
0.46
699
6744
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
745
7167
1.43
2.31
5.1
4.6
mmol/l
1.6
1.5
0.47
679
6560
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
749
7213
1.44
2.30
5.2
4.6
mmol/l
4.7
4.8
0.66
694
6654
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
151
1204
1.31
2.29
2.6
2.6
e6/l
0.7
1.2
2.57
77
679
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
42
263
1.63
2.28
2.0
1.9
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
12
47
2.58
2.28
2.8
2.5
%
34.8
41.3
—
6
18
(3021589) Normoblasts [#/volume] in Blood
363
3215
1.23
2.27
11.7
9.4
e9/l
0.0
0.0
0.11
303
2627
(3043410) Blood group antigens tested for on Red Blood Cells
8
23
3.50
2.27
1.3
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
221
1854
1.26
2.26
2.8
2.6
umol/l
331.4
5769.7
6.12
188
1589
(3042631) Mycobacterium sp identified in Specimen
19
93
2.07
2.23
2.0
2.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
48
2.52
2.19
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
38
236
1.64
2.14
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
39
245
1.62
2.11
1.5
1.5
—
100.0
—
0
11
(3022217) INR in Platelet poor plasma by Coagulation assay
112
867
1.34
2.09
12.9
22.9
inr
1.0
1.2
1.78
20
116
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
91
682
1.38
2.09
2.7
2.3
u/l
97.7
34.7
0.52
73
570
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
306
2681
1.23
2.08
4.3
4.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
271
1.58
2.04
2.4
2.4
g/l
9.1
10.6
1.80
35
233
(36304419) Bacteria [Presence] in Urine
225
1913
1.24
2.02
3.1
2.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
38
2.65
2.01
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
59
412
1.47
2.01
1.4
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
230
1964
1.24
1.99
3.1
3.0
e6/l
0.3
0.5
0.59
161
1475
(40768441) Liver Pathology biopsy report
13
57
2.30
1.98
1.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
21
3.35
1.97
1.1
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
290
1.55
1.97
2.5
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
290
1.55
1.97
2.5
2.3
g/l
7.5
7.6
0.17
33
224
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
290
1.55
1.97
2.4
2.3
g/l
3.6
3.7
0.27
31
213
(3003181) Sodium [Moles/volume] in Urine
23
127
1.83
1.95
1.4
1.4
mmol/l
64.9
59.4
0.22
17
110
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
93
708
1.35
1.95
1.7
1.7
%
1.5
1.5
0.01
86
616
(1761482) Bacteria [#/volume] in Urine by Culture
8
189
0.42
1.94
7.1
4.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
16
3.77
1.93
1.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
16
3.77
1.93
1.3
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
11
45
2.46
1.93
2.9
1.8
e6/l
734.4
654.5
—
5
19
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
58
2.26
1.91
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
55
384
1.46
1.89
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
151
1237
1.27
1.87
5.0
4.9
ug/l
1.6
2.5
2.27
133
1113
(3045424) Erythrocytes [Presence] in Urine
21
115
1.85
1.84
1.4
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
17
3.55
1.84
1.3
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
73
2.07
1.81
4.5
3.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
24
138
1.76
1.81
2.8
3.1
e9/l
3.8
4.5
1.16
24
138
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
272
1.53
1.80
1.9
2.4
g/l
3.1
3.1
0.08
32
217
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
200
1.62
1.80
1.4
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
60
431
1.42
1.78
5.5
8.6
mmol/l
24.5
24.8
0.43
55
408
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
719
6928
1.31
1.76
4.5
4.1
mmol/l
1.3
1.3
0.12
654
6300
(3013512) EKG study
251
2189
1.21
1.74
3.9
3.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
125
1.78
1.73
1.1
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
244
2124
1.21
1.73
3.1
3.1
e6/l
35.5
54.2
0.52
178
1620
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
103
1.86
1.73
1.4
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
24
2.93
1.72
1.6
2.0
%
166.7
122.6
—
7
24
(3014133) Dog dander IgE Ab [Units/volume] in Serum
13
61
2.15
1.72
1.1
1.0
u/ml
1.8
2.4
—
8
19
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
48
2.31
1.71
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
120
967
1.28
1.70
5.2
4.7
%
33.8
33.0
0.29
76
637
(3017704) Immunofixation for Urine
10
42
2.40
1.68
2.3
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
134
1.74
1.67
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
667
6379
1.24
1.67
18.0
15.3
%
39.7
39.4
0.38
464
4432
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
142
1.71
1.66
3.1
3.4
%
58.0
59.1
0.15
24
142
(4094501)
32
205
1.58
1.65
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
51
362
1.44
1.63
7.9
10.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
14
3.59
1.61
1.4
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
56
2.16
1.61
1.0
1.1
u/ml
8.0
3.4
—
6
16
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
32
2.51
1.60
1.3
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
32
2.51
1.60
1.3
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
135
1113
1.25
1.59
2.6
2.8
e6/l
2.3
3.2
0.74
61
588
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
7
26
2.71
1.58
2.1
1.7
pmol/l
13.6
15.7
—
7
19
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
69
521
1.35
1.56
1.1
1.2
iu/ml
105.0
133.9
0.40
32
209
(3010144) Erythrocytes [#/volume] in Synovial fluid
14
71
1.99
1.54
1.3
1.3
e6/l
206743.3
105547.9
—
8
49
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
30
193
1.58
1.53
1.3
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
80
620
1.32
1.52
4.5
4.0
%
1.7
1.0
0.43
23
174
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
173
1473
1.22
1.52
2.7
2.5
e6/l
4.0
6.8
2.63
147
1295
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
25
154
1.64
1.51
1.4
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
16
86
1.88
1.51
2.9
2.0
pg
32.1
32.2
0.01
16
86
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
21
2.87
1.50
1.2
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
72
551
1.34
1.50
4.1
4.1
%
0.1
0.7
0.45
21
133
(3003888) Timothy IgE Ab [Units/volume] in Serum
15
80
1.89
1.45
1.0
1.1
u/ml
8.0
2.8
—
9
35
(3003396) Base excess in Arterial blood by calculation
96
769
1.28
1.44
8.5
7.8
mmol/l
0.9
1.3
0.68
77
618
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
76
590
1.32
1.44
1.7
2.4
ug/l
5.3
6.9
0.60
63
521
(3021440) Promyelocytes/100 leukocytes in Blood
75
583
1.32
1.41
4.4
4.1
%
0.3
0.1
0.45
21
157
(3021879) Hepatitis B virus core Ab [Presence] in Serum
58
434
1.36
1.40
1.4
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
37
255
1.47
1.40
1.6
1.4
—
—
—
0
0
(3000492) Spirometry study
84
664
1.30
1.40
1.5
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
96
1.79
1.39
2.9
2.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
35
239
1.49
1.39
1.7
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
119
1.70
1.38
1.7
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
82
1.84
1.36
3.4
3.6
—
—
—
0
0
(3009343) pH of Capillary blood
54
402
1.37
1.36
4.4
3.2
ph
7.4
7.4
—
10
53
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
120
1.68
1.35
1.4
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
39
0.00
1.34
0.0
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
52
386
1.37
1.33
4.4
3.2
mmol/l
1.4
2.0
0.69
42
302
(3002179) Metamyelocytes/100 leukocytes in Blood
72
562
1.31
1.33
4.4
3.9
%
0.5
0.6
0.20
19
123
(3048879) Bone marrow aspiration report
5
18
2.79
1.28
2.4
2.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
26
170
1.55
1.27
1.4
1.3
miu/ml
199.8
215.6
0.09
12
76
(3015235) Bicarbonate [Moles/volume] in Capillary blood
25
162
1.56
1.27
2.9
2.8
mmol/l
24.8
25.5
0.53
20
143
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
35
2.30
1.27
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
35
2.30
1.27
1.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
35
2.30
1.27
2.9
3.5
u/ml
375.0
1184.7
—
8
35
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
25
2.41
1.24
2.3
5.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
36
2.23
1.24
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
36
2.23
1.24
1.3
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
100
1.71
1.24
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
45
2.01
1.23
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
29
196
1.50
1.23
1.7
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
19
2.64
1.21
4.4
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
19
2.64
1.21
1.6
1.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
13
71
1.84
1.20
1.0
1.0
u/ml
0.2
0.7
—
6
14
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
14
79
1.79
1.17
1.4
2.0
pmol/l
227.9
207.7
0.33
14
71
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
166
1.52
1.16
1.6
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
191
1.48
1.15
1.3
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
21
134
1.58
1.15
4.0
4.1
mmol/l
2.4
2.9
0.47
16
88
(3023511) Choriogonadotropin [Units/volume] in Urine
12
65
1.86
1.14
1.3
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
40
2.01
1.12
1.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
31
2.27
1.10
1.3
4.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
41
305
1.36
1.07
2.3
2.1
g/l
1.4
1.5
0.50
35
270
(3052851) Hemolysis interference index of Serum or Plasma
31
220
1.43
1.06
2.3
2.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
92
766
1.23
1.04
1.6
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
34
2.07
1.03
1.7
1.4
nmol/l
122.0
151.2
—
7
34
(3002385) Erythrocyte distribution width [Ratio]
614
5910
1.15
1.02
20.3
17.3
%
13.6
13.7
0.87
607
5782
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
95
797
1.22
1.00
3.1
4.2
ug/l
3.7
15.3
1.39
71
646
(3009508) Creatinine [Moles/volume] in Urine
253
2302
1.14
1.00
3.0
3.1
mmol/l
6.4
7.0
1.64
211
1914
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
35
2.01
1.00
1.1
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
59
469
1.28
0.99
3.6
3.0
pmol/l
4.3
4.5
1.04
53
406
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
92
770
1.22
0.99
1.6
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
23
2.18
0.98
1.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
116
1.56
0.97
1.7
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
50
391
1.30
0.96
1.5
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
243
2211
1.14
0.96
3.0
3.2
mg/l
1242.6
327.4
0.86
138
1318
(3035637) Corticotropin [Mass/volume] in Plasma
14
85
1.66
0.94
1.1
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
18
117
1.55
0.94
3.3
2.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
92
775
1.21
0.94
1.6
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
70
1.72
0.93
1.3
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
52
1.74
0.92
1.7
1.9
%
13.3
10.9
—
9
52
(40767503) Oxygen content in Capillary blood by calculation
20
134
1.50
0.92
3.4
2.5
%
16.1
16.0
0.04
11
68
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
78
1.68
0.92
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
143
1.48
0.90
1.4
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
63
1.76
0.90
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
127
1.51
0.89
1.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
42
1.91
0.88
1.8
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
170
1.42
0.86
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
49
390
1.27
0.84
1.7
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
65
1.70
0.82
2.3
1.6
%
24.2
30.4
—
5
42
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
206
1.37
0.82
3.3
2.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
73
1.65
0.82
1.3
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
29
216
1.36
0.79
1.3
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
24
0.00
0.79
0.0
1.2
—
107.7
—
0
19
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
33
1.82
0.79
1.7
1.7
ug/l
73.3
54.4
—
6
33
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
25
0.00
0.79
0.0
1.1
—
0.7
—
0
15
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
82
1.59
0.78
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
123
1.47
0.78
5.2
3.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
231
2506
0.89
0.78
2.6
3.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
13
83
1.58
0.75
1.2
2.0
%
90.6
89.6
0.45
13
83
(3037121) Protein [Mass/volume] in Urine
31
236
1.33
0.75
2.2
3.3
g/l
0.1
0.2
1.39
13
76
(40760888) Immunoglobulin light chains.free panel - Serum
23
167
1.39
0.74
3.4
4.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
26
193
1.36
0.74
1.9
1.8
iu/l
2.6
5.2
—
9
61
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
108
1.49
0.74
1.8
1.2
u/ml
413.1
295.4
—
7
64
(3020682) Albumin/Creatinine [Ratio] in Urine
252
2334
1.12
0.74
3.8
3.9
mg/mmol
3.6
7.4
1.98
144
1378
(3044941) Cell count panel - Synovial fluid
17
117
1.46
0.72
1.3
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
53
436
1.23
0.71
4.3
6.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
71
602
1.20
0.71
3.2
2.6
ml/min/173m2
69.8
66.3
0.43
36
243
(3024263) Appearance of Synovial fluid
7
40
1.76
0.71
1.3
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
160
1.39
0.71
1.7
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
41
1.71
0.70
1.0
1.6
ug/l
5.4
8.5
—
7
36
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
77
1.57
0.69
1.0
1.1
u/ml
0.3
0.6
—
5
27
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.86
0.68
2.2
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
144
1.40
0.68
3.2
2.1
g/l
126.1
128.0
0.15
12
105
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
53
439
1.22
0.68
1.7
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
121
0.57
0.67
1.1
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
12
78
1.55
0.65
1.3
1.2
u/l
49.3
53.4
—
7
57
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
32
252
1.28
0.63
5.2
3.5
mmol/l
24.7
25.1
0.35
32
237
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
73
629
1.18
0.63
3.6
3.3
ng/l
102.7
79.6
0.59
64
551
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
25
191
1.32
0.61
1.8
2.4
g/l
3.7
3.5
0.24
25
186
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
21
0.00
0.60
0.0
1.2
—
4.5
—
0
16
(44806420)
0
21
0.00
0.60
0.0
2.7
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
8
52
1.54
0.59
1.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
35
282
1.25
0.59
2.4
3.0
u/ml
149.4
761.7
0.65
29
243
(3003694) ABO and Rh group [Type] in Blood
194
1795
1.11
0.58
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
89
1.47
0.58
1.5
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
123
1.39
0.58
1.9
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
123
1.39
0.58
1.6
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
38
310
1.24
0.58
2.4
3.4
mmol/l
24.4
24.4
0.04
32
278
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
112
1005
1.13
0.57
4.4
4.3
%
20.5
21.4
0.26
47
475
(3039443) Prostate specific Ag panel - Serum or Plasma
5
86
0.58
0.56
2.0
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
31
384
0.80
0.56
3.2
3.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
57
489
1.18
0.53
2.5
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
83
734
1.15
0.53
3.1
3.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
108
1.40
0.53
1.3
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
15
108
1.40
0.53
1.8
1.4
u/ml
76.5
110.8
—
6
22
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
66
1.52
0.52
2.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
66
1.52
0.52
2.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
66
1.52
0.52
2.3
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
63
1.43
0.52
1.1
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
97
0.62
0.52
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
28
224
1.26
0.51
1.4
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
15
109
1.38
0.51
1.2
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
153
1.31
0.50
1.3
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
41
1.47
0.50
1.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
41
1.47
0.50
1.2
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
45
1.56
0.49
1.7
2.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
11
76
1.45
0.48
1.8
1.3
u/l
40.1
34.8
0.21
11
61
(3024928) Oxygen saturation in Venous blood
19
146
1.31
0.47
2.1
2.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
48
1.46
0.47
1.9
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
48
1.46
0.47
1.1
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
36
301
1.21
0.46
4.6
3.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
94
1.39
0.46
1.2
1.1
u/ml
8.3
1.8
—
5
34
(3014051) Protein [Presence] in Urine by Test strip
23
183
1.26
0.45
1.8
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
51
1.38
0.44
1.3
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
35
294
1.20
0.43
1.9
2.1
nmol/l
14.8
12.7
0.72
30
266
(4034850)
18
229
0.78
0.43
11.1
9.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
221
1.23
0.43
1.3
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
25
203
1.24
0.42
2.1
1.5
—
—
—
0
0
(4024509)
10
70
1.43
0.42
1.7
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
41.4
—
0
5
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.2
—
1.7
—
0
16
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
34
1.47
0.40
3.0
2.5
ug/l
31.1
259.3
—
5
29
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
18
0.00
0.40
0.0
2.1
—
7.8
—
0
11
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
171
0.76
0.39
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
5
35
1.43
0.39
1.6
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
169
1.25
0.39
2.2
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
169
1.25
0.39
1.7
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
36
1.39
0.38
1.2
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
67
1.35
0.38
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
170
1.24
0.37
1.5
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
8
114
0.70
0.37
1.1
1.3
nmol/l
—
0.6
—
0
9
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
2.8
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
2.8
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
2.8
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
2.8
1.6
—
—
—
0
0
(4211845)
5
37
1.35
0.37
3.8
2.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
125
1.29
0.37
1.2
1.5
—
—
—
0
0
(4268621)
9
70
1.29
0.36
2.4
2.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
76
0.66
0.36
1.4
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
162
1.24
0.36
1.8
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
78
0.64
0.35
1.0
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
99
1.32
0.35
1.1
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
56
626
0.89
0.35
3.2
3.3
mmol/l
1.5
2.2
0.79
45
507
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
82
1.35
0.34
1.9
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
50
559
0.89
0.32
1.4
1.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
47
1.28
0.32
1.2
1.4
u/l
5.5
6.4
—
6
38
(3020891) Body temperature
32
276
1.17
0.32
3.5
4.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
220
1.19
0.32
1.3
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
32
369
0.86
0.32
1.7
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
28
239
1.18
0.31
2.4
2.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
52
1.35
0.31
1.4
1.5
g/l
0.9
1.0
—
7
52
(3018405) Lactate [Moles/volume] in Arterial blood
29
249
1.17
0.31
3.6
4.3
mmol/l
1.4
1.3
0.10
29
244
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
75
1.34
0.30
1.0
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
75
1.34
0.30
2.9
2.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
93
1.29
0.30
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
146
1380
1.07
0.29
2.9
2.6
mosm/kgh2o
488.7
527.2
1.36
115
1173
(3000764) Benzodiazepines [Presence] in Urine
17
139
1.23
0.29
1.2
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
107
0.75
0.29
1.1
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
57
1.23
0.29
1.6
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
24
280
0.85
0.28
1.8
2.0
ug/l
1.3
2.1
0.22
18
253
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
103
1.27
0.28
1.2
1.2
u/ml
1.3
1.7
—
7
28
(3002523) Influenza virus A Ag [Presence] in Specimen
12
94
1.28
0.28
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
62
1.29
0.28
1.4
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
140
1.22
0.27
1.2
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
140
1.22
0.27
1.2
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
131
1.23
0.27
1.3
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
66
1.21
0.26
3.5
2.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
67
1.20
0.26
1.5
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
86
1.28
0.26
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
77
1.30
0.26
1.7
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
77
1.30
0.26
1.6
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
73
1.24
0.25
2.1
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
13
105
1.24
0.25
1.0
2.2
—
27.9
—
0
27
(44790049)
10
78
1.29
0.24
1.5
1.6
—
—
—
0
0
(44806118)
10
78
1.29
0.24
1.5
1.6
—
—
—
0
0
(44790048)
10
78
1.29
0.24
1.5
1.6
—
—
—
0
0
(44790047)
10
78
1.29
0.24
1.5
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
81
0.74
0.24
1.0
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
208
1.16
0.24
1.9
2.6
u/ml
0.3
0.4
1.01
11
125
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
106
1.23
0.23
1.3
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
5
38
1.32
0.23
1.4
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
38
342
1.12
0.23
1.5
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
77
719
1.08
0.23
3.1
3.0
ug/l
0.7
0.7
0.70
50
474
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
97
1.24
0.23
1.2
1.5
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
39
1.28
0.23
5.4
20.1
nmol/l
872.4
1574.9
—
5
39
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
79
1.27
0.22
2.5
2.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
42
1.19
0.21
1.6
3.6
—
—
—
0
0
(44806071)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
89
1.24
0.21
1.3
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
13
0.00
0.21
0.0
1.7
—
1.3
—
0
13
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
9
115
0.78
0.20
1.1
1.3
nmol/l
0.6
0.6
—
9
107
(40761536) Microorganisms panel - Urine sediment
64
599
1.07
0.19
4.1
3.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
137
1.17
0.19
1.3
1.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
81
1.24
0.19
1.3
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
18
206
0.87
0.18
1.7
2.0
%
95.7
91.2
0.40
18
196
(3041096) Erythrocytes [Presence] in Urine by Automated
192
1860
1.04
0.18
3.3
3.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
60
562
1.07
0.17
11.4
7.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
61
1.15
0.17
3.3
2.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
12
141
0.85
0.16
5.5
3.1
nmol/l
0.8
0.8
—
6
113
(3032773) Endomysium IgG Ab [Titer] in Serum
8
70
1.14
0.16
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
273
1.10
0.16
2.8
1.8
mg/l
3.2
4.6
0.30
24
211
(4306422)
11
92
1.20
0.16
1.0
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
24
216
1.11
0.15
4.0
4.2
mmol/l
3.8
3.8
0.64
24
197
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
84
1.19
0.14
1.3
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
99
0.81
0.13
1.1
1.3
nmol/l
—
—
—
0
0
(40768793) Breast Pathology biopsy report
26
238
1.10
0.13
1.4
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
52
492
1.06
0.12
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
19
171
1.11
0.12
1.9
2.4
ug/min
52.1
98.7
0.54
11
101
(4146454)
10
85
1.18
0.12
3.8
2.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
181
1.11
0.12
2.9
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
39
366
1.07
0.12
1.6
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
38
359
1.06
0.10
1.4
1.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
46
1.09
0.09
1.4
1.1
u/l
95.4
14.2
—
5
40
(44813793)
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
5
48
1.04
0.09
1.4
1.1
u/l
99.2
72.8
—
5
43
(3012441) Differential panel - Pleural fluid
5
48
1.04
0.09
1.4
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.0
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
1.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
64
0.78
0.08
3.2
2.3
%
13.8
13.2
—
5
64
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
68
1.03
0.08
4.6
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
71
0.84
0.07
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
75
1.07
0.07
1.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
30
284
1.06
0.07
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
78
1.03
0.07
1.4
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
89
1.13
0.07
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
101
0.89
0.06
1.0
1.0
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
18
168
1.07
0.06
1.5
1.2
e6/l
114.8
14.7
0.41
12
127
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
55
562
0.98
0.03
1.8
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
132
1.06
0.02
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
93
1.08
0.02
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
11
105
1.05
0.00
1.3
1.2
u/ml
1.2
3.3
—
6
43
(4281824)
11
107
1.03
0.00
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
123
0.98
0.00
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
131
0.99
0.00
1.2
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
131
0.99
0.00
1.9
2.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
131
0.99
0.00
1.2
1.4
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
72
0.97
0.00
2.1
1.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
7.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
202.2
—
0
5
(4212803)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
95
0.95
0.00
1.1
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
120
1.00
0.00
1.1
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
6.5
—
0
9
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
6.7
—
0
7
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.8
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
6
67
0.89
0.00
3.0
4.1
—
36.6
—
0
17
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.1
—
0.3
—
0
8
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ORAL_LICHEN_PLANUS and mortality.

Females

Parameter HR [95% CI] p-value
K11_ORAL_LICHEN_PLANUS 0.757 [0.57, 1.01] 0.055
Birth year 0.998 [0.99, 1.01] 0.563

During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 1994 females with K11_ORAL_LICHEN_PLANUS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_ORAL_LICHEN_PLANUS.

N-year risk Females Males
1 0.095% No data
5 0.439% No data
10 1.153% No data
15 2.282% No data
20 4.174% No data

Relationships between endpoints

↥

Index endpoint: K11_ORAL_LICHEN_PLANUS – Oral lichen ruber planus

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data